Connect to other sites within the UBM Medica Network
Oncology Drug Snapshot: Axitinib (Inlyta)
This oncology drug snapshot takes a look at axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
Renal Cancer Management in a Patient With Chronic Kidney Disease
A 69-year-old man presented in the urology clinic for evaluation of bilateral renal masses, discovered incidentally during routine exams for follow-up of his chronic kidney disease.
Neutrophil-to-Lymphocyte Ratio Linked to mRCC Outcomes
Metastatic renal cell carcinoma patients with an elevated neutrophil-to-lymphocyte ratio at baseline had inferior outcomes compared to those with a low ratio.
Current Guidelines Miss One-Third of RCC Recurrences
If physicians are following the current NCCN and AUA renal cell carcinoma surveillance guidelines, they could be missing as many as one-third of recurrences.
Smoking May Increase Risk of Second Primary Cancer
Cancer survivors are at an increased risk for developing a second smoking-associated cancer if they smoked cigarettes prior to their first cancer diagnosis.
Pancreatic Metastases From Renal Cell Carcinoma Treated With Stereotactic Body Radiation Therapy
In this edition of our ongoing series, the authors present two cases involving renal cell carcinoma patients treated with SBRT for pancreatic metastases.
Higher B6 Levels Linked With Lower Kidney Cancer Risk
Participants from two separate studies with higher levels of vitamin B6 were found to have a lower risk for renal cell carcinoma.
By clicking Accept, you agree to become a member of the UBM Medica Community.